Facebook
X
LinkedIn
ForwardRTTDC 5th Edition .5 Day Course (Non-CME)
The Resource-Variable Trauma Team Development Course (RTTDC®) 5th Edition is intended to improve the quality of care in rural communities by developing a timely, organized, and systemic response to the care of the trauma patient. It teaches teamwork where care begins, at the first point of contact when the patient arrives. It stands beside the people who show up for their communities, caring for their neighbors, families, friends, and fellow responders. Together the team acts early, organizes care, and saves lives. This plan, guided by flexible educators and grounded in real need, turned a small idea into a course that endures. It continues to grow from its North American roots to reach teams worldwide, including those in austere and military environments.
Complimentary Access to the MyATLS App:
RTTDC 5th Edition learners who have not previously accessed the Pro version can receive 2 months of free access to MyATLS Pro.
Learners can redeem their free access using the following promotion codes:
- Apple/iOS Promotion Code: NEWSTUDENTATLS
- Android Promotion Code: LEARNER2MONTHS
Note: These promotion codes are for specific Trauma Education learners only and should not be shared outside of your course site(s). Once a learner redeems a code, Pro access remains active for 2 months. After the promotional period, learners may continue their subscription or cancel at any time. Promotion codes will change periodically, and the most current code will always be listed in the LMS. The MyATLS App complements the RTTDC course but does not count toward course credit or completion.
Use the QR codes below to download the MyATLS App today!
APPLE:
GOOGLE:
Contact
For any questions about the RTTDC course, please contact us [email protected].
Target Audience
The intended audience includes individuals who are involved in the care of the injured patient, including physicians, physician assistants, nurse practitioners, nurses, prehospital personnel, technicians, hospital administration, and support staff.
Learning Objectives
Upon completing the Resource-Variable Trauma Team Development (RTTDC) course, the participants will be able to:
- Organize a resource-variable trauma response team with defined roles and responsibilities.
- Prepare the resource-variable facility for optimal care of the injured patient.
- Develop the needed skills to assess and resuscitate a trauma patient, being able to rapidly identify and address life-threatening injuries.
- Promptly identify patients requiring transfer to a higher level of care (within 15 minutes) and initiating the transfer process early to avoid delay.
- Communicate effectively with the team and between facilities.
- Establish a working relationship between the rural hospital and the regional trauma facility, fostering the growth and development of both trauma programs.
- Strengthen the resource-variable hospital's trauma performance improvement process.
- Identify local resources and limitations.
- Establish a process improvement process.
Disclosure Information
In accordance with ACCME regulations (ACCME Standard 3), the American College of Surgeons must ensure that anyone who is able to control the content of the activity has disclosed all financial relationships with any ineligible companies in the 24 months prior to their involvement in the educational activity. There is no minimum financial threshold; we ask that you disclose all financial relationships, regardless of the amount, with ineligible companies. You should disclose all financial relationships regardless of the potential relevance of each relationship to this education.
Ineligible Company: Companies that are ineligible to be accredited in the ACCME system (ineligible companies) are those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients. |
Financial Relationships: Financial relationships are relevant if the following three conditions are met for the individual who will control content of the education: 1) a financial relationship, in any amount, exists between the person in control of content and an ineligible company; 2) the financial relationship existed in the last 24 months; 3) the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. |
All CME Planners and Speakers /Moderators/Discussants/Authors/Editors involved in the development and/or presentation of CME content must complete this form. This form must be updated whenever circumstances require.
Disclosures
RTTDC 5th Edition Disclosures:
(All relevant financial conflicts have been mitigated)
Jeffrey D. Kerby, MD, PhD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Eileen Bulger, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Avery Nathens, MD, PhD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Michael Person, MD, MPH, MBA, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Elisha Brownson, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Sonia Agnew, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Wendy Allen, RN, BSN
No relevant financial relationship(s) with ineligible companies to disclose
Benjamin Axtman, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Erin Beck, RN, MS, CEN, CCRN, TCRN
No relevant financial relationship(s) with ineligible companies to disclose
Richard Betzold, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Robel Beyene, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Erika Bisgaard, MD
No relevant financial relationship(s) with ineligible companies to disclose
Darrell Boone, MD, FRCSC, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Alexandra Briggs, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Michael A. Brozik, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Jeanette Capella, MD, MEd, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Thomas Causer, BSN, RN, RTT, PHRN
No relevant financial relationship(s) with ineligible companies to disclose
Anthony Christiano, MD, FAAOS
No relevant financial relationship(s) with ineligible companies to disclose
Timothy Chung, DO
No relevant financial relationship(s) with ineligible companies to disclose
Meri Clare, MBA, BSN, RN
No relevant financial relationship(s) with ineligible companies to disclose
Julia Coleman, MD, MPH, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Terry Collins, RN, TCRN
No relevant financial relationship(s) with ineligible companies to disclose
Alisa Cross, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Benjamin Davis, MD, MBA, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Kate Dellonte, RN, MBA, BSN
No relevant financial relationship(s) with ineligible companies to disclose
Bradley Dennis, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Stacy Dougherty-Welch, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Marie Dowling, MD
No relevant financial relationship(s) with ineligible companies to disclose
Ryan Dumas, MD, FACS
Dr. Dumas has received Honorarium for his consultancy at Teleflex and Surgical Safe Technologies
Bradley Dennis, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Brian Eastridge, MD, FACS, COL (Ret), MC, USA
No relevant financial relationship(s) with ineligible companies to disclose
Russell Dumire, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Mary Edwards, MD, MBA, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Charity Evans, MD, MHCM, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Mary Fallat, MD
No relevant financial relationship(s) with ineligible companies to disclose
Brent Feldt, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Mason G. Fisher, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Manuel Galaviz, MSN, RN
No relevant financial relationship(s) with ineligible companies to disclose
Lawrence Gillman, MD, MEd, FRCSC, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Darlene Gondell, MSN, RN
No relevant financial relationship(s) with ineligible companies to disclose
Sarah Grimes, MD, FACOG
No relevant financial relationship(s) with ineligible companies to disclose
Jenny Guido, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Jennifer Hagen, MD, FACS, FAAOS
No relevant financial relationship(s) with ineligible companies to disclose
Mustafa Mark Hamed, MD, MBA, MPH
No relevant financial relationship(s) with ineligible companies to disclose
Mohammad Zain Hashmi, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Emily Hillmer, MD
No relevant financial relationship(s) with ineligible companies to disclose
John Holcomb, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Joseph Johnson, MD, FACS, FAAOS, FAOA
Dr. Johnson received financial compensation and research funding from Stryker and Ortho Xcel for his educational consultancy and research
Hee Soo Jung, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Kevin Kemp, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Jacob Knudsvig-Partida, FNP-S
No relevant financial relationship(s) with ineligible companies to disclose
Angela Ling, MSN, FNP-C
No relevant financial relationship(s) with ineligible companies to disclose
Hassan Mashbari, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Shawna Morrisey, DO, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Jordan Nantais, MD, PhD
No relevant financial relationship(s) with ineligible companies to disclose
Karen Orman, MD, FAAP
No relevant financial relationship(s) with ineligible companies to disclose
Peter Pappas, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Caroline Park, MD, MPH, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Nirav Patel, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
David Paul, MD, MS
No relevant financial relationship(s) with ineligible companies to disclose
Maria Paulsen, BSN, RN
No relevant financial relationship(s) with ineligible companies to disclose
Nakul Raykar, MD, MPH
No relevant financial relationship(s) with ineligible companies to disclose
Debra Roberts, MD, PhD
No relevant financial relationship(s) with ineligible companies to disclose
Katie Russell, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Gregory Schaefer, DO, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Tami Schnetter, BSN, RN, TCRN
No relevant financial relationship(s) with ineligible companies to disclose
David Schultz, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
David Shapiro, MD, MHCM, FACS
Dr. Shapiro received honoraria from Octapharma for his role as advisor/speaker
Richard Sidwell, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Jennifer Silvis, DO, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Dustin Smoot, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Mary Stuever, DO, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Avery Thompson, MD, MPH
No relevant financial relationship(s) with ineligible companies to disclose
Rodrigo Vaz Ferreira, MD, PhD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Michael Vella, MD, FACS
Dr. Vella received Honoraria for his speaking role with Teleflex Corporation
Marta Whyte, MD, MSc, FRCSC
No relevant financial relationship(s) with ineligible companies to disclose
Alison Wilson, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Deidre Wyrick, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Markus Ziesmann, MD, MSc, FRCSC
Dr. Ziesmann is the Medical Director of BodyLuxe Contouring and Aesthetics
At the completion of this course, learners are awarded a Certificate of Completion.
Available Credit
- 0.00 Certificate of Completion
Hardware/Software Requirements
Compatible Browsers
Windows: Google Chrome (latest version), Firefox (latest version), Microsoft Edge (latest version)
Mac: Google Chrome (latest version), Safari (latest version), Firefox (latest version)
Required Browser Settings
Pop-ups: Pop-ups must be enabled on your web browser for you to see the modules after you click on “Launch.”
Javascript: JavaScript must be enabled for published courses to work.
Font Downloads: Font downloads must be enabled to see the correct fonts and characters.
Tablets
Ensure your ringer (or volume) is turned on and not muted or you will not be able to hear the sound when viewing videos or the modules.
The modules are not optimized for viewing on smartphones due to the complexity of the modules.
Additional Software
Adobe Acrobat Reader
Microsoft Office® Word